Our global pages
Close- Global home
- About us
- Global services/practices
- Industries/sectors
- Our people
- Events/webinars
- News and articles
- Eversheds Sutherland (International) Press Hub
- Eversheds Sutherland (US) Press Hub
- News and articles: choose a location
- Careers
- Careers with Eversheds Sutherland
- Careers: choose a location
Developing medical AI systems. Overview of MDR and AI legislation implications
- Poland
- Technology
09-11-2022
Artificial intelligence (AI) systems are increasingly applied in more and more disciplines, one of which is healthcare. When creating AI systems, developers focus first on their functionality and effectiveness. However, another challenge that developers may face is legal uncertainty. This uncertainty is, to some degree, addressed in the proposal for an Artificial Intelligence Act published on 21 April 2022 (the AI Act).(1) Due to its general and broad scope, although the AI Act does not specifically address AI in healthcare, it will also apply to medical devices to which the EU Medical Devices Regulation (MDR) applies. Currently, the AI Act is being discussed in the European Parliament's committees.(2) This article is part of a series on developing medical AI systems.
Click here to read the full article by Jowita Prokop and Malte Scheel (part 1) >
This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.
- Assignment of arbitral claims and arbitral awards: uncertain legal landscape in France
- New Employment Bills the Consumer Sector should be aware of
- A round-up podcast: ESG for the UK asset management industry
- Education briefing - Student accommodation: A vision for the future
- Distribution of surplus assets in a creditors’ voluntary liquidation